Bio-Connect
Western blot analysis of I-309 using anti-I-309 antibody (PB9028).
Western blot analysis of I-309 using anti-I-309 antibody (PB9028).
Western blot analysis of I-309 using anti-I-309 antibody (PB9028).

Anti-I-309/CCL1 IGF1R Antibody Picoband(r)

Research Use Only
PB9028
Boster Bio
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetIGF1R
Price on request
100 ug
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Anti-CCL1 Antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    No cross reactivity with other proteins.
  • Application Supplier Note
    WB: The detection limit for I-309 is approximately 0.25ng/lane under reducing conditions. Tested Species: In-house tested species with positive results. Other applications have not been tested. Optimal dilutions should be determined by end users.
  • Applications
    Western Blot, ELISA
  • Applications Supplier
    ELI, WB
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    500 ug/ml
  • Formulation
    Lyophilized
  • Gene ID3480
  • Target name
    IGF1R
  • Target description
    insulin like growth factor 1 receptor
  • Target synonyms
    CD221; IGF-I receptor; IGFIR; IGFR; insulin-like growth factor 1 receptor; JTK13; soluble IGF1R variant 1; soluble IGF1R variant 2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP08069
  • Protein Name
    Insulin-like growth factor 1 receptor
  • Scientific Description
    Boster Bio Anti-I-309/CCL1 IGF1R Antibody Picoband® catalog # PB9028. Tested in ELISA, WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
  • Reactivity
    Human
  • Reactivity Supplier
    Human
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis. Liu SS et al., 2021 Sep 14, Immunity
    Read more